XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Common stock
Preferred stock
Nonvested restricted stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Total
Beginning balance, value at Dec. 31, 2022 $ 80 $ (3,306) $ 119,027 $ (13,410) $ 192,121 $ 294,512
Beginning balance shares outstanding at Dec. 31, 2022 8,011,045          
Net income 2,703 2,703
Proceeds from exercise of stock options 17 17
Proceeds from exercise of stock options (in Shares) 1,000          
Issuance of restricted stock, net of forfeitures (1,521) 1,521
Issuance of restricted stock, net of forfeitures (in Shares) 35,930          
Compensation expense related to restricted stock, net of tax 365 365
Compensation expense related to stock options, net of tax 118 118
Other comprehensive income (loss) 1,635 1,635
Ending balance, value at Mar. 31, 2023 $ 80 (4,462) 120,683 (11,775) 194,824 299,350
Ending balance shares outstanding at Mar. 31, 2023 8,047,975          
Beginning balance, value at Dec. 31, 2023 $ 81 (3,596) 121,777 (11,342) 205,547 312,467
Beginning balance shares outstanding at Dec. 31, 2023 8,088,186            
Net income 2,522 2,522
Proceeds from exercise of stock options 167 167
Proceeds from exercise of stock options (in Shares) 11,000          
Issuance of restricted stock, net of forfeitures $ 1 (2,112) 2,111
Issuance of restricted stock, net of forfeitures (in Shares) 56,923          
Compensation expense related to restricted stock, net of tax 451 451
Compensation expense related to stock options, net of tax 104 104
Other comprehensive income (loss) (455) (455)
Ending balance, value at Mar. 31, 2024 $ 82 $ (5,257) $ 124,159 $ (11,797) $ 208,069 $ 315,256
Ending balance shares outstanding at Mar. 31, 2024 8,156,109